EUVIMEDEUVIMED entdecken
Crossref

Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years

Sigrid Bjerge Gribsholt iD, Szimonetta Komjáthiné Szépligeti, Henrik Toft Sørensen, Noel T Mueller, Margaret R Karagas, Vera Ehrenstein iD

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Sigrid Bjerge Gribsholt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Pediatric Obesity, Registries, Anti-Infective Agents. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University and Aarhus University Hospital, Denmark, The Danish Council for Independent Research, Danmarks Frie Forskningsfond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To examine associations of prenatal and early‐life anti‐infective exposures with obesity at 7 years.

Methods

In this nationwide, registry‐based, prevalence study, we included all children with an anthropometric assessment at age 7 years from the Children's Database and linked their data with Danish population‐based registries from 2001 to 2018. We defined exposure to anti‐infectives (anti‐bacterials, anti‐virals, and anti‐fungals) by outpatient dispensings or by infection diagnoses at hospital encounters. The earliest date defined the exposure timing category: prenatal (−9 months– < 0 months), infancy (0– < 2 years), and early childhood (2– < 5 years). We computed prevalence ratios (aPRs) for associations of anti‐infective exposure with obesity prevalence at 7 years of age, adjusting for maternal and perinatal factors.

Results

We included 460 363 children (51% boys). Prevalence of obesity at 7 years of age was 38% higher (aPR = 1.38, 95% confidence interval (CI): 1.27–1.49) among children exposed to any anti‐infective, 21% higher (aPR = 1.21, 95% CI: 1.12–1.31) among children exposed to anti‐infectives in infancy, and 14% higher (aPR = 1.14, 95% CI: 1.03–1.26) among children exposed to anti‐infectives in early childhood. Exposure to anti‐bacterials was associated with obesity in a similar time‐dependent pattern [prenatal: aPR = 1.39 (95% CI: 1.29–1.50), infancy: aPR = 1.21 (95% CI: 1.12–1.30), and early childhood: aPR = 1.14 (95% CI: 1.03–1.25)]. For anti‐virals and anti‐fungals, exposure during infancy and early childhood was associated with larger aPRs than prenatal exposure. Furthermore, obesity prevalence increased monotonically with number of the anti‐infective prescriptions.

Conclusion

These findings suggest that prenatal and early‐life exposure to anti‐infectives increases the risk of childhood obesity and that the magnitude of the associations depends on anti‐infective type, timing, and dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal Exposure Delayed EffectsPediatric ObesityRegistriesAnti-Infective AgentsHumansFemalePregnancyChildMaleDenmarkPrevalenceInfantChild, PreschoolInfant, Newborn

Stichwörter der Autor:innen

anti‐bacterialsanti‐fungalsanti‐infectivesanti‐viralschildhood obesity

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Department Pediatrics Section of Nutrition, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, Colorado School of Public Health, Aurora, Colorado, USA.

ORCID-Profile: Sigrid Bjerge Gribsholt, Vera Ehrenstein

Förderung

  • Department of Clinical Epidemiology, Center for Population Medicine, Aarhus University and Aarhus University Hospital, Denmark
  • The Danish Council for Independent Research
  • Danmarks Frie Forskningsfond

Zitieren

APA

Gribsholt, S. B., Szépligeti, S. K., Sørensen, H. T., Mueller, N. T., Karagas, M. R., & Ehrenstein, V. (2024). Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70055

Vancouver

Gribsholt SB, Szépligeti SK, Sørensen HT, Mueller NT, Karagas MR, Ehrenstein V. Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70055

BibTeX
@article{Gribsholt2024,
  author = {Gribsholt, Sigrid Bjerge and Szépligeti, Szimonetta Komjáthiné and Sørensen, Henrik Toft and Mueller, Noel T and Karagas, Margaret R and Ehrenstein, Vera},
  title = {Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.70055}
}
Kostenlos starten →